dr. andrew zelenetz discusses treatment options for dlbcl
Published 12 years ago • 485 plays • Length 1:24Download video MP4
Download video MP3
Similar videos
-
3:19
andrew zelenetz, md, discusses the alexander trial investigating auto3 as treatment for dlbcl
-
1:49
dr. andrew zelenetz on targeted therapies for diffuse large b-cell lymphoma
-
1:58
dr. zelenetz on current treatment options for mcl
-
54:13
treatment options for dlbcl
-
9:05
understanding car t-cell therapy for lymphoma with andrew zelenetz, md, phd
-
2:30
dr. andrew zelenetz on the treatment of hematologic malignancies
-
29:00
dlbcl in 2023: top docs discuss the latest in diffuse large b-cell lymphoma | treatments & research
-
0:59
dr nowakowski on the current treatment landscape for dlbcl
-
9:16
understanding diffuse large b-cell lymphoma
-
1:01:22
what to know about minimal residual disease | lrf webinars
-
48:44
diffuse large b cell lymphoma - overview of standard therapy with michael dickinson
-
1:33
dr. zelenetz on treatment for patients with cll who fail on ibrutinib or idelalisib
-
5:26
treatment options for diffuse large b-cell lymphoma (dlbcl)
-
0:42
dr. zelenetz discusses brentuximab vedotin
-
5:44
treatment of newly diagnosed dlbcl
-
56:44
treatment innovation in dlbcl: real-world insight on integrating antibodies and cellular therapy
-
2:03
novel treatment approaches for early-stage dlbcl
-
1:10
dr. kieron dunleavy discusses treatment options for primary mediastinal b cell lymphoma
-
7:23
diffuse large b-cell lymphoma (dlbcl) regimens
-
4:46
current treatment options for older patients with dlbcl
-
3:56
treatment options for relapsed diffuse large b-cell lymphoma
-
21:26
polatuzumab fda approval in dlbcl (polarix) & swog s1826 nivo vs. bv in hodgkin's lymphoma